Urology · Dartmouth, MA
NPI
1184069056
Since 2013
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
535 Faunce Corner Rd
Dartmouth, MA, 02747
Phone (508) 961-0606
Groups this clinician bills Medicare through
Medicare paid, 2024
$244K
4,181 services
Medicare patients, 2024
1,011
Average age 73
Drug cost, 2024
$244K
2,707 prescriptions
Company payments, 2025
$17.24
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Haralampos Kamenidis was code 99214 (office e&m - established), 848 times for 614 patients. In total Haralampos Kamenidis billed 4,181 services in 89 codes, and Medicare paid $244K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 848 | 614 | $92.24 | $78K |
| 81003 Clinical Chemistry | Office | 454 | 359 | $2.20 | $999 |
| 51798 Ultrasound - Nonspecific | Office | 426 | 337 | $8.74 | $3,725 |
| 99213 Office E&M - Established | Office | 273 | 237 | $66.21 | $18K |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 193 | 183 | $83.18 | $16K |
| 52000 Cystourethroscopy | Office | 139 | 112 | $190.75 | $27K |
| 36415 Venipuncture Blood Collection | Office | 135 | 129 | $8.65 | $1,168 |
| 99204 Office E&M - New | Office | 112 | 112 | $110.57 | $12K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 90 | 25 | $141.24 | $13K |
| 84153 Clinical Chemistry | Office | 88 | 87 | $18.02 | $1,586 |
| 96402 Chemotherapy Administration | Office | 62 | 28 | $27.99 | $1,735 |
| 96372 Injection Administration | Office | 62 | 12 | $10.49 | $651 |
| 99232 Hospital E&M - Subsequent | Facility | 50 | 34 | $61.81 | $3,091 |
| 52332 Cystourethroscopy | Facility | 29 | 27 | $91.73 | $2,660 |
| 99222 Hospital E&M - Initial | Facility | 29 | 28 | $102.63 | $2,976 |
By year: 2022 $225K for 5,438 services; 2023 $246K for 5,043 services; 2024 $244K for 4,181 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 454 | 359 | $2.20 | $999 |
| 36415 Venipuncture Blood Collection | 135 | 129 | $8.65 | $1,168 |
| 84153 Clinical Chemistry | 88 | 87 | $18.02 | $1,586 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 28 | 28 | $18.92 | $530 |
| 82565 Clinical Chemistry | 12 | 12 | $5.02 | $60.24 |
Medicare prescription drug claims, 2024
In 2024, the drug Haralampos Kamenidis prescribed most often to Medicare patients was Tamsulosin Hcl, with 824 prescriptions and refills. In total Haralampos Kamenidis wrote 2,707 Medicare prescriptions that cost $244K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 824 | 1,712 | 230 | $16K |
| Trospium Chloride Generic | 289 | 531 | 85 | $22K |
| Finasteride Generic | 224 | 497 | 59 | $3,096 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 199 | 363 | 61 | $4,295 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 121 | 125 | 96 | $481 |
| Cephalexin Generic | 118 | 118 | 95 | $462 |
| Myrbetriq Mirabegron | 110 | 140 | 33 | $62K |
| Silodosin Generic | 79 | 151 | 26 | $6,912 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 73 | 157 | 20 | $1,507 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 67 | 72 | Under 11 | $993 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 65 | 67 | 54 | $794 |
| Gemtesa Vibegron | 54 | 64 | 13 | $31K |
| Ciprofloxacin Hcl Generic | 44 | 44 | 41 | $243 |
| Trimethoprim Generic | 37 | 37 | Under 11 | $1,195 |
| Solifenacin Succinate Generic | 34 | 72 | 11 | $1,602 |
Brand drugs: 227 claims; generic drugs: 2,480 claims; opioid claims: 44.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Haralampos Kamenidis $17.24 ($17.24 in general payments such as food, travel and fees) from 1 company. The largest payer was Medtronic, Inc. with $17.24.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 1 | $17.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.